ConductScience.org, home
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
API referenceFor AI assistants

Trial · NCT02829320

Results by group103

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 103

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Hgb at Week 4All Participants0.7995% Confidence Interval 0.53 to 1.05G/dL
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants<= -2.00Participants
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants> -2.0 to -1.00Participants
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants> -1.0 to 04Participants
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants> 0 to 1.013Participants
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants> 1.0 to 2.011Participants
Number of Participants by Hgb Change From Baseline Category at Week 4All Participants> 2.00Participants
Hgb Values at the Indicated Time PointsAll ParticipantsDay 19.10Standard Deviation 0.696G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 49.90Standard Deviation 0.907G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 810.76Standard Deviation 0.957G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 1211.09Standard Deviation 1.117G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 1611.38Standard Deviation 1.286G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 2011.34Standard Deviation 1.169G/dL
Hgb Values at the Indicated Time PointsAll ParticipantsWeek 2411.12Standard Deviation 1.210G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 40.79Standard Deviation 0.673G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 81.66Standard Deviation 0.773G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 121.98Standard Deviation 0.984G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 162.28Standard Deviation 1.248G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 202.24Standard Deviation 1.174G/dL
Change From Baseline in Hgb at the Indicated Time PointsAll ParticipantsWeek 242.01Standard Deviation 1.121G/dL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02829320/results

API referenceFor AI assistants